Cargando…

Ursodeoxycholic Acid Treatment–Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis

Treatment of primary biliary cholangitis (PBC) can improve the GLOBE score. We aimed to assess the association between changes in the GLOBE score (ΔGLOBE) and liver transplantation (LT)–free survival in patients with PBC who were treated with ursodeoxycholic acid (UDCA). METHODS: Among UDCA-treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Veer, Rozanne C., van Hooff, Maria C., Corpechot, Christophe, Thorburn, Douglas, Invernizzi, Pietro, Lammers, Willem J., Janssen, Harry L.A., Battezzati, Pier M., Nevens, Frederik, Lindor, Keith D., Floreani, Annarosa, Ponsioen, Cyriel Y., Mayo, Marlyn J., Parés, Albert, Mason, Andrew L., Kowdley, Kris V., Trivedi, Palak J., Hirschfield, Gideon M., Goet, Jorn C., Bruns, Tony, Dalekos, George N., Gatselis, Nikolaos K., Verhelst, Xavier, Hansen, Bettina E., Harms, Maren H., van der Meer, Adriaan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298170/ https://www.ncbi.nlm.nih.gov/pubmed/36621963 http://dx.doi.org/10.14309/ajg.0000000000002128

Ejemplares similares

Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: de Veer, Rozanne C., et al.
Publicado: (2022)

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists
por: Trivedi, Palak J., et al.
Publicado: (2015)

Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis
por: Harms, Maren H., et al.
Publicado: (2020)

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid
por: Hochberg, Jessica T., et al.
Publicado: (2023)

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid
por: de Graaf, Kathy L., et al.
Publicado: (2018)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
por: Martinez-Gili, Laura, et al.
Publicado: (2023)

Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa
Publicado: (2020)

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
por: Hirschfield, Gideon M., et al.
Publicado: (2023)

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010)

The Immunogenetics of Autoimmune Cholestasis
por: Trivedi, Palak J., et al.
Publicado: (2016)

COVID-19 and Autoimmune Liver Diseases
por: Floreani, Annarosa, et al.
Publicado: (2022)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
por: Pearson, Talima, et al.
Publicado: (2019)

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
por: Kowdley, Kris V., et al.
Publicado: (2020)

Combination of vial culture and broad-range PCR for the diagnosis of spontaneous bacterial peritonitis: experience in a Greek tertiary care hospital
por: Malli, E., et al.
Publicado: (2018)

Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
por: Fleminger, J, et al.
Publicado: (2020)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Update on the Pharmacological Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
por: Choi, S. W., et al.
Publicado: (1991)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
por: Subramanian, Subbaya, et al.
Publicado: (2020)

Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
por: Invernizzi, Federica, et al.
Publicado: (2022)

Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis
por: Kamp, Eline JCA, et al.
Publicado: (2022)

An immunocompetent patient presenting with severe septic arthritis due to Ralstonia pickettii identified by molecular-based assays: a case report
por: Makaritsis, Konstantinos P, et al.
Publicado: (2009)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
por: Tonin, Fabio, et al.
Publicado: (2018)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease
por: Floreani, Annarosa, et al.
Publicado: (2020)

Food and Nutrition in the Pathogenesis of Liver Damage
por: Mega, Andrea, et al.
Publicado: (2021)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Endoscopic vacuum-assisted surgical closure (EVASC) of anastomotic defects after low anterior resection for rectal cancer; lessons learned
por: Talboom, Kevin, et al.
Publicado: (2022)

Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature
por: Gatselis, Nikolaos K, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_trec35r3eq1trrfm9g3s1b7b74